C/O ADMA BIOLOGICS, INC., RAMSEY, NJ
Issues Statement Refuting Unsubstantiated, Misleading and Inaccurate Allegations by Culper Research
Announces $125 Million Accelerated Share Repurchase with JPMorgan as Part of a Planned $200 Million 2026 Total Share Repurchase Initiative
Reports Record Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Investor Presentation
Financial Results, Press Release
Material Contracts, End of Material Contract, Financial Results, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Shareholder votes
Announces First Quarter 2025 Financial Results and Provides Business Update
FY 2024
Q3
Q2
Q1
Notice of Late Filing for Annual Report
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Certification of Termination of Registration of a Class of Security
Registration of Securities
Additional Proxy Materials
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Amended Schedule 13G - Ownership Report
Notice of Proposed Sale of Securities
Submission Upload
Correspondence